See Dr. Weiss’s Collection of Publications and Reports

On this page you will find Dr. Weiss’s extensive collection of peer reviewed publications, reviews, editorials, statements, conference reports, and letters, followed by his book chapters and research abstracts.

Peer Reviewed Research Publications

94 publications listed most recent to earliest, beginning in 1987

  1. Weiss DJ, Segal K, Casaburi R, Hayes J, Tashkin D.  Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levels.  Respiratory Research, in press 2021.

  2. Lopes-Pacheco M, Carvalho L, Cruz FF, Khoury M, Weiss DJ, Rocco PRM. Mitochondria-rich Fraction Isolated from Mesenchymal Stromal Cells Reduce Lung and Distal Organ Injury in Experimental Sepsis Critical Care Medicine, in press 2021.

  3. Enes SR, Hampton TH, Barua J, McKenna DH, dos Santos CC, Amiel E, Asahre A, Liu KD, Krasnodembskaya AD, English K, Stanton BA, Rocco PRM, Matthay MA, Weiss DJ. Healthy versus Inflamed Lung Environments Differentially Effect MSCs.  European Respiratory Journal.  In press 2021.

  4. L. Yan, Y. Song, K. Xia, P. He, F. Zhang, S. Chen, Ro. Pouliot, D. J. Weiss, R. Tandon, J. T. Bates, D. R. Ederer, D. Mitra, P. Sharma, A. Davis, R. J. Linhardt. Heparan sulfates from bat and human lung and their binding to the spike protein of SARS-CoV-2 virus,” Carbohydrate Polymers, in press, 2021.

  5. Thiebes AL, Uhl FE, Hauser M, Cornelissen CG, Jockenhoevel S, Weiss DJ.  Endoscopic atomization of mesenchymal stromal cells: in vitro study for local cell therapy of the lungs.  Cytotherapy epub.1/29/21.

  6. Silva JD, Sue Y, Calfee CS, Delucchi KL. Weiss DJ, McAuley DF, O’Kane C, Krasnodembskaya AD.  MSC extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS.  In press, Eur Resp J, 2020.

  7. Abreu et al (Weiss DJ).  Differential effects of the cystic fibrosis lung inflammatory environment on mesenchymal stromal cells.  American Journal of Physiology - Lung Cellular & Molecular Physiology. 319(6):L908-L925, 2020.

  8. Pouliot RA; Young BM; Link PA; Park HE; Kahn AR; Shankar K; Schneck MB; Weiss DJ; Heise RL.  Porcine Lung-Derived Extracellular Matrix Hydrogel Properties Are Dependent on Pepsin Digestion Time.  Tissue Engineering - Part C: Methods. 26(6):332-346, 2020 Jun.

  9. Silva LHA; Silva MC; Vieira JB; Lima ECD; Silva RC; Weiss DJ; Morales MM; Cruz FF; Rocco PRM. Magnetic targeting increases mesenchymal stromal cell retention in lungs and enhances beneficial effects on pulmonary damage in experimental silicosis.  Stem Cells Translational Medicine. 9(10):1244-1256, 2020.

  10. Park HE, Gasek N, Hwang J, Weiss DJ, Lee PC.  Effect of temperature on gelation and cross-linking of gelatin methacryloyl for biomedical applications.  Physics of Fluids.32:3, DOI: 10.1063/1.5144896. 2020

  11. Uhl FE, Zhang F, Pouliot RA, Uriarte JJ, Rolandsson Enes S, Han X, Ouyang Y, Xia K, Westergren-Thorsson G, Malmström A, Hallgren O, Linhardt RJ, Weiss DJ.  Functional role of glycosaminoglycans in decellularized lung extracellular matrix. Acta Biomater. 2020 Jan 15;102:231-246. 

  12. Abreu SC, Enes SR, Dearbron J, Goodwin M, Coffey A, Borg ZD, dos Santos CC, Wargo MJ, Cruz FF, Loi R, DeSarno M, Ashikaga T, Antunes MA, Rocco PRM, Liu KD, Lee JW, Matthay MA, McKenna DH, Weiss DJ. Lung Inflammatory Environments Differentially Alter Mesenchymal Stromal Cell Behavior.  Am J Physiol Lung Cell Mol Physiol. 2019 Dec 1;317(6):L823-L831.

  13. Silva JD, Lopes-Pacheco M, de Castro LL, Kitoko JZ, Trivelin SA, Amorim NR, Capelozzi VL, Morales MM, Gutfilen B, de Souza SAL, Weiss DJ, Diaz BL, Rocco PRM.  Eicosapentaenoic acid potentiates the therapeutic effects of adipose tissue-derived mesenchymal stromal cells on lung and distal organ injury in experimental sepsis.  Stem Cell Res Ther. 2019 Aug 23;10(1):264. doi: 10.1186/s13287-019-1365-z. PMID: 31443678.

  14. Silva JD, de Castro LL, Braga CL, Oliveira GP, Trivelin SA, Barbosa-Junior CM, Morales MM, Dos Santos CC, Weiss DJ, Lopes-Pacheco M, Cruz FF, Rocco PRM. Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology.   Stem Cells Int. 2019 Aug 21;2019:8262849. doi: 10.1155/2019/8262849. eCollection 2019.  PMID: 31531026.

  15. Abreu SC, Xisto DG, Oliviera TB, Blanco NG, de Castro LL, Kitoko JZ, Olsen PC, Lopes-Pacheco M, Morales MM, Weiss DJ, Rocco PRM. Serum from Asthmatic Mice Potentiates the Therapeutic Effects of Mesenchymal Stromal Cells in Experimental Allergic Asthma.  Stem Cells Transl Med. 2018 Nov 13. doi: 10.1002/sctm.18-0056. [Epub ahead of print]  PMID:30426724.

  16. Abreu SC, Lopes-Pacheco M, da Silva AL, Xisto DG, de Oliveira TB, Kitoko JZ, de Castro LL, Amorim NR, Martins V, Silva LHA, Gonçalves-de-Albuquerque CF, de Castro Faria-Neto HC, Olsen PC, Weiss DJ, Morales MM, Diaz BL, Rocco PRM. Eicosapentaenoic Acid Enhances the Effects of Mesenchymal Stromal Cell Therapy in Experimental Allergic Asthma.  Front Immunol. 2018 May 24;9:1147. doi: 10.3389/fimmu.2018.01147.  PMID: 29881388

  17. Cruz FF, Rocco PRM, Weiss DJ. hMSCs as an alternative therapeutic option for asthma with neutrophil mediated inflammation. Exp Mol Med. 2018 Jun 7;50(6):72. doi: 10.1038/s12276-018-0072-7. PMID:29884808.

  18. Silva LHA, Silva SM, Lima ECD, Silva RC, Weiss DJ, Morales MM, Cruz FF, Rocco PRM. Effects of static magnetic fields on natural or magnetized mesenchymal stromal cells: Repercussions for magnetic targeting.  Nanomedicine. 2018 Jun 19;14(7):2075-2085. doi: 10.1016/j.nano.2018.06.002.PMID: 29933023.

  19. Wrenn SM, Griswold ED, Uhl FE, Uriarte JJ, Park HE, Coffey AL, Dearborn JS, Ahlers BA, Deng B, Lam YW, Huston DR, Lee PC, Wagner DE, Weiss DJ. Avian lungs: A novel scaffold for lung bioengineering. PLoS One. 2018 Jun 27;13(6):e0198956. doi: 10.1371/. PMID: 29949597

  20. Armitage J, Tan D, Troedson R, Young P, Lam KV, Shaw K, Sturm M, Weiss DJ, Moodley Y.  Mesenchymal stromal cell infusion modulates systemic immunological responses in stable COPD patients: A phase I pilot study. Eur Respir J. 2018 Mar 1;51(3). pii: 1702369. doi: 10.1183/13993003.02369-2017. Print 2018 Mar. PMID: 29348155.

  21. Van der Velden J, Wagner D, Lahue K, Abdalla S, Lam Y, Weiss DJ, Janssen-Heininger Y.  TGF-β1-induced deposition of provisional extracellular matrix by tracheal basal cells promotes epithelial-to-mesenchymal transition in a JNK1-dependent manner.  Am J Physiol Lung Cell Mol Physiol. 2018 Jun 1;314(6):L984-L997. doi: 10.1152/ajplung.00053.2017. Epub 2018 Feb 22. PMID: 29469614.

  22. Uhl FE, Wagner DE, Weiss DJ. Preparation of Decellularized Lung Matrices for Cell Culture and Protein Analysis. Methods Mol Biol. 2017;1627:253-283. doi: 10.1007/978-1-4939-7113-8_18.

  23. Silva LH, Cruz FF, Morales MM, Weiss DJ, Rocco PR.  Magnetic targeting as a strategy to enhance therapeutic effects of mesenchymal stromal cells. Stem Cell Res Ther. 2017 Mar 9;8(1):58.

  24. Abreu SC, Antunes MA, Xisto DG, Cruz FF, Branco VC, Bandeira E, Zola Kitoko J, de Araújo AF, Dellatorre-Texeira L, Olsen PC, Weiss DJ, Diaz BL, Morales MM, Rocco PRM.Bone Marrow, Adipose, and Lung Tissue-Derived Murine Mesenchymal Stromal Cells Release Different Mediators and Differentially Affect Airway and Lung Parenchyma in Experimental Asthma. Stem Cells Transl Med. 2017 Jun;6(6):1557-1567.

  25. de Castro LL, Xisto DG, Kitoko JZ, Cruz FF, Olsen PC, Redondo PAG, Ferreira TPT, Weiss DJ, Martins MA, Morales MM, Rocco PRM.  Human adipose tissue mesenchymal stromal cells and their extracellular vesicles act differentially on lung mechanics and inflammation in experimental allergic asthma.  Stem Cell Res Ther. 2017 Jun 24;8(1):151. doi: 10.1186/s13287-017-0600-8.

  26. Kim SY, Burgess JK, Wang Y, Kable EP, Weiss DJ, Chan HK, Chrzanowski W.  Atomized Human Amniotic Mesenchymal Stromal Cells for Direct Delivery to the Airway for Treatment of Lung Injury.  J Aerosol Med Pulm Drug Deliv. 2016 Dec;29(6):514-524

  27. de Oliveira HG, Cruz FF, Antunes MA, de Macedo Neto AV, Oliveira GA, Svartman FM, Borgonovo T, Rebelatto CL, Weiss DJ, Brofman PR, Morales MM, Lapa E Silva JR, Rocco PR. Combined Bone Marrow-Derived Mesenchymal Stromal Cell Therapy and One-Way Endobronchial Valve Placement in Patients with Pulmonary Emphysema: A Phase I Clinical Trial.  Stem Cells Transl Med. 2017 Mar;6(3):962-969. doi: 10.1002/sctm.16-0315. Epub 2016 Dec 9.

  28. Kim SY, Burgess JK, Wang Y, Kable EP, Weiss DJ, Chan HK, Chrzanowski W.  Atomized Human Amniotic Mesenchymal Stromal Cells for Direct Delivery to the Airway for Treatment of Lung Injury.  J Aerosol Med Pulm Drug Deliv. 2016 May 17.

  29. Scarritt ME, Pashos NC, Motherwell JM, Eagle ZR, Burkett BJ, Gregory AN, Mostany R, Weiss DJ, Alvarez DF, Bunnell BA.  Re-endothelialization of rat lung scaffolds through passive, gravity-driven seeding of segment-specific pulmonary endothelial cells. J Tissue Eng Regen Med. 2018 Feb;12(2):e786-e806.

  30. Pothen JJ, Rajendran V, Wagner D, Weiss DJ, Smith BJ, Ma B, Bates JH.  A Computational Model of Cellular Engraftment on Lung Scaffolds.  Biores Open Access. 2016 Oct 1;5(1):308-319.

  31. Platz J, Bonenfant NR, Uhl FE, Coffey AL, McKnight T, Parsons C, Sokocevic D, Borg ZD, Lam YW, Deng B, Fields JG, DeSarno M, Loi R, Hoffman AM, Bianchi J, Dacken B, Petersen T, Wagner DE, Weiss DJ.  Comparative Decellularization and Recellularization of Wild-Type and Alpha 1,3 Galactosyltransferase Knockout Pig Lungs: A Model for Ex Vivo Xenogeneic Lung Bioengineering and Transplantation.  Tissue Eng Part C Methods. 2016 Aug;22(8):725-739. Epub 2016 Jul 14.

  32. Simonson OE, Mougiakakos D, Heldring N, Bassi G, Johansson HJ, Dalén M, Jitschin R, Rodin S, Corbascio M, El Andaloussi S, Wiklander OP, Nordin JZ, Skog J, Romain C, Koestler T, Hellgren-Johansson L, Schiller P, Joachimsson PO, Hägglund H, Mattsson M, Lehtiö J, Faridani OR, Sandberg R, Korsgren O, Krampera M, Weiss DJ, Grinnemo KH, Le Blanc K.   In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.  Stem Cells Transl Med. 2016 Jun;5(6):845.

  33. Zvarova B, Uhl FE, Uriarte JJ, Borg ZD, Coffey AL, Bonenfant NR, Weiss DJ, Wagner DE. Residual Detergent Detection Method for Nondestructive Cytocompatibility Evaluation of Decellularized Whole Lung Scaffolds.  Tissue Eng Part C Methods. 2016 May;22(5):418-28.

  34. Cruz FF, Borg ZD, Goodwin M, Coffet AL, Wagner DE, Rocco PRM, Weiss DJ.  CD11b+ and Sca-1+ Cells Exert the Main Beneficial Effects of Systemically Administered Bone Marrow-Derived Mononuclear Cells in a Murine Model of Mixed Th2/Th17 Allergic Airway Inflammation.  Stem Cells Transl Med. 2016 Apr 5:488-99.

  35. Godin LM, Sandri BJ, Wagner DE, Meyer CM, Price AP, Akinnola I, Weiss DJ, Panoskaltsis-Mortari A.  Decreased Laminin Expression by Human Lung Epithelial Cells and Fibroblasts Cultured in Acellular Lung Scaffolds from Aged Mice. PLoS One. 2016 Mar 8;11(3). 

  36. Cruz FF, Borg ZD, Goodwin M, Sokocevic D, Wagner DE, Coffey A, Antunes M, Robinson KL, Mitsialis SA, Kourembanas S, Thane K, Hoffman AM, McKenna DH, Rocco PR, Weiss DJ. Systemic Administration of Human Bone Marrow-Derived Mesenchymal Stromal Cell Extracellular Vesicles Ameliorates Aspergillus Hyphal Extract-Induced Allergic Airway Inflammation in Immunocompetent Mice. Stem Cells Transl Med. 2015 Nov;4(11):1302-16.

  37. Cruz FF, Borg ZD, Goodwin M, Sokocevic D, Wagner D, McKenna DH, Rocco PR, Weiss DJ. Freshly thawed and continuously cultured human bone marrow-derived mesenchymal stromal cells comparably ameliorate allergic airways inflammation in immunocompetent mice. Stem Cells Transl Med. 2015 Jun;4(6):615-24.

  38. Lathrop MJ, Sage EK, Macura SL, Brooks EM, Bonenfant NR, Sokocevic D, MacPherson MB, Beuschel SL, Dunaway CW, Shukla A, Janes SM, Steele C, Mossman BT, Weiss DJ.  Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma. Cancer Gene Ther 22(1): 44-45, 2015.

  39. Crabbé A, Liu Y, Sarker SF, Bonenfant NR, Barrila J, Borg ZD, Lee JJ, Weiss DJ, Nickerson CA.  Recellularization of decellularized lung scaffolds is enhanced by dynamic suspension culture. PLoS One. 2015 May 11;10(5):e0126846

  40. Abreu SC, Antunes MA, Mendonca L, Branco VC, de Melo EB, Olsen PC, Diaz BL, Weiss DJ, Paredes BD, Xisto DG, Morales MM, Rocco PR. Effects of bone marrow mononuclear cells from healthy or ovalbumin-induced lung inflammation donors on recipient allergic asthma mice. Stem Cell Res 5(5): 108, 2014.

  41. LaFrancesca S, Ting AE, Sakamoto J, Rhudy J, Bonenfant NR, Borg ZD, Cruz FF, Goodwin M, Lehman NA, Taggart JM, Deans R, Weiss DJ. Multipotent adult progenitor cells decrease cold ischemic injury in ex vivo perfused human lungs: an initial pilot and feasibility study. Transplant Res 3(1): 19, 2014.

  42. Antunes MA, Abreu SC, Cruz FF, Teixeira AC, Lopes-Pacheco M, Bandeira E, Diaz BL, Takyia CM, Freitas I, Rocha NN, Capelozzi VL, Xisto DG, Weiss DJ, Morales MM, Rocco PRM.   Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema. Respir Res 15:118, 2014

  43. Wagner D, Fenn S, Bonenfant N, Marks E, Borg Z, Saunders P, Oldinski RA, Weiss DJ. Design and Synthesis of an Artificial Pulmonary Pleura for High Throughput Studies in Acellular Human Lungs. Cell Mol Bioeng 7(2):184-195, 2014.

  44. Lau AN, Curtis SJ, Fillmore CM, Rowbotham SP, Mohseni M, Wagner DE, Beede AM, Montoro DT, Sinkevicious KW, Walton ZE, Barrios J, Weiss DJ, Camargo FD, Wong KK, Kim CF. Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis. Embo J 33(5): 468-81, 2014.

  45. Wagner DE, Bonenfant NR, Parsons C, Sokocevic D, Borg ZS, Lathrop M, Lam YW, Deng B, DeSarno M, Ashikaga T, Loi R, Weiss DJ. Comparative decellularization and recellularization of normal versus emphysematous human lungs. Biomaterials 35(10): 3281-97, 2014.

  46. Wagner DE, Bonenfant NR, Sokocevic D, DeSarno M, Borg Z, Parsons C, Brooks EM, Platz J, Khalpey Z, Hoganson DM, Deng B, Lam YW, Oldinski RA, Ashikaga T, Weiss DJ. Three-dimensional scaffolds of acellular human and porcine lungs for high throughput studies of lung disease and regeneration. Biomaterials 35(9): 2664-79, 2014.

  47. Lathrop MJ, Brooks EM, Bonenfant NR, Sokocevic D, Borg ZD, Goodwin M, Loi R, Cruz FF, Dunaway CW, Steele C, Weiss DJ.  Mesenchymal Stromal Cells Mediate Aspergillus Hyphal Extract-Induced Allergic Airways Inflammation by Inhibition of the Th17 Signaling Pathway.  Stem Cells Transl Med 3(2): 194-205, 2014.

  48. Martin RA. Ather JL. Daggett R. Hoyt L. Alcorn JF. Suratt BT. Weiss DJ. Lundblad LK. Poynter ME. The Endogenous Th17 Response in NO2-Promoted Allergic Airway Disease Is Dispensable for Airway Hyperresponsiveness and Distinct from Th17 Adoptive Transfer. PLoS ONE [Electronic Resource]. 8(9):e74730, 2013.

  49. Girard ED, Jensen TJ, Vadasz SD, Blanchette AE, Zhang F, Moncada C, Weiss DJ, Finck CM. Automated procedure for biomimetic de-cellularized lung scaffold supporting alveolar epithelial transdifferentiation. Biomaterials 34(38):10043-55, 2013.

  50. Eisenhauer P, Earle B, Loi R, Sueblinvong V, Goodwin M, Allen GB, Lundblad L, Mazan MR, Hoffman AM, Weiss DJ. Endogenous Distal Airway Progenitor Cells, Lung Mechanics, and Disproportionate Lobar Growth following Long-Term Post-Pneumonectomy in Mice. Stem Cells 31(7):1330-9, 2013.

  51. Weiss DJ, Casaburi R, Flannery R, LeRoux-Williams M, Tashkin DP. A Placebo-Controlled Randomized Trial of Mesenchymal Stem Cells in Chronic Obstructive Pulmonary Disease. Chest 143(6):1590-8. 2013.

  52. Sokocevic D, Bonenfant N, Wagner DE, Borg ZD, Lathrop M, Lam YW, Deng B, DeSarno M, Ashikaga T, Loi R, Hoffman AM, Weiss DJ. The Effect of Age and Emphysematous and Fibrotic Injury on the Re-Cellularization of De-Cellularized Lungs. Biomaterials 34(13):3256-69, 2013.

  53. Bonenfant N, Sokocevic D, Wagner DE, Borg ZD, Lathrop M, Lam YW, Deng B, DeSarno M, Ashikaga T, Loi R, Weiss DJ. The Effects of Storage and Sterilization on De-Cellularized and Re-Cellularized Whole Lung. Biomaterials 34(13):3231-45 2013.

  54. Beckett T, Bonneau L, Howard A, Blanchard J, Borda J, Weiner DJ, Wang L, Gao GP, Kolls JK, Bohm R, Liggitt D, Weiss DJ. Inhalation of nebulized perfluorochemical enhances recombinant adenovirus and adeno-associated virus-mediated gene expression in lung epithelium. Human Gene Ther Part B Methods 23(2):98-110, 2012.

  55. Bonvillain RW, Danchuk S, Sullivan DE, Betancourt AM, Semon JA, Eagle ME, BS1, Mayeux JP, Gregory AN, Wang G, Townley I, Borg Z, Weiss DJ, MD, Bunnell, BA. A non-human primate model of lung regeneration: detergent-mediated decellularization and re-cellularization with mesenchymal stem cells. Tissue Engineering Part A. 18(23-24):2437-52, 2012.

  56. Entezari M, Sitapara R, LeClair L, Wargo MJ, Li J, Wang H, Yang H, Phan BD, Javdan M, Miller EJ, Tracey KJ, Weiss DJ, Mantell LL. Inhibition of HMGB1 enhances bacterial clearance and protects against P. aeruginosa pneumonia in Cystic Fibrosis. Molecular Medicine 18:477-85, 2012.

  57. Jensen T, Roszell B, Zang F, Girard E, Matson A, Thrall R, Jaworski DM, Hatton C, Weiss DJ, Finck CM. A Rapid Lung De-Cellularization Protocol Supports Embryonic Stem Cell Differentiation In Vitro and Following Implantation. Tissue Engineering Part C Methods 18(8):632-46, 2012.

  58. Longmire TA, ikonomou L, Hawkins F, Christodoulou C, Cao Y, Jena JC, Kwok LW, Mou H, Rajagopal J, Shen SS, Dowton AA, Serra M, Weiss DJ, Green MD, Snoeck HW, Ramirez MI, Kotton DN. Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells. Cell Stem Cell 10(4):398-411, 2012.

  59. Wallis JM, Borg ZD, Daly AB, Deng B, Ballif BA, Allen GB, Jaworski DM, Weiss DJ. Comparative Assessment of Detergent-Based Protocols for Mouse Lung De-Cellularization and Re-Cellularization. Tissue Eng Part C 18(6):420-32, 2012.

  60. Daly AB, Wallis JM, Borg ZD, Bonvillain RW, Deng B, Ballif BA, Jaworski DM, Allen GB, Weiss DJ Initial Binding and Re-Cellularization of De-Cellularized Mouse Lung Scaffolds with Bone Marrow-Derived Mesenchymal Stromal Cells Tissue Engineering Part A 18(1-2):1-16, 2012.

  61. Weiss DJ, Bertoncello I, Borok Z, Kim C. Panoskaltsis-Mortari A. Reynolds S. Rojas M. Stripp B. Warburton D. Prockop DJ. Stem cells and cell therapies in lung biology and lung diseases. Proceedings of the American Thoracic Society. 8(3):223-72, 2011.

  62. Bozyk PD, Popova AP, Bentley JK, Goldsmith AM, Linn MJ, Weiss DJ, Hershenson MB. Mesenchymal stromal cells from neonatal tracheal aspirates demonstrate a pattern of lung-specific gene expression. Stem Cells and Development 20(11):1995-2007, 2011.

  63. Goodwin M, Sueblinvong V, Eisenhauer P, Ziats NP, Leclair L, Poynter ME, Steele C, Rincon M, Weiss DJ. Bone Marrow Derived Mesenchymal Stromal Cells Inhibit Th2-Mediated Allergic Airways Inflammation in Mice. Stem Cells. 29(7):1137-48, 2011.

  64. Hillegass JM, Blumen SR, Cheng K, MacPherson MB, Aleexeva V, Lathrop SA, Beuschel SL, Steinbacher JL, Butnor KL, Ramos-Niño ME, Shukla ME, James TA, Weiss DJ, Taatjes DJ, Pass H, Carbone M, Landry CC, and Mossman BT. Increased Efficacy of Doxorubicin Delivered in Multifunctional Microparticles for Mesothelioma Therapy. International Journal of Cancer. 129(1):233-44, 2011.

  65. Somers A, Ford C, Murphy GJ, Jyh-Chang J, Jenny J, Weiss DJ, Gadue P, Mills JA, Lafyatis R, Smith B,Mostoslavsky G, Kotton, DN. Generation of transgene-free lung disease-specific human iPS cells using a single excisable lentiviral stem cell cassette. Stem Cells 28(10):1728-40, 2010.

  66. Petty JM, Lenox CC, Weiss DJ, Poynter ME, Suratt BT. Crosstalk between CXCR4/SDF-1 and VLA-4/VCAM-1 pathways regulates neutrophil retention in the bone marrow. J Immunol 182(1):604-12, 2009.

  67. Kozul CD, Hampton TH, Davey JC, Gosse JA, Nomikos AP, Eisenhauer PL, Weiss DJ, Thorpe JE, Ihnat MA, Hamilton JW. Chronic exposure to arsenic in the drinking water alters the expression of immune response genes in mouse lung. In press Environmental Health Perspectives. Environ Health Perspect 117:1108-15. 2009.

  68. Sueblinvong V, Loi R, Eisenhauer PL, Bernstein IM, Suratt BT, Spees JL, Weiss DJ. Derivation of Lung Epithelium from Human Cord Blood-Derived Mesenchymal Stem Cells. Am J Resp Crit Care Med177:701-711, 2008.

  69. Levis J, Loi R, Butnor KJ, Vacek P, Steele C, Mossman BT, Weiss DJ. Decreased Asbestos-Induced Lung Inflammation and Fibrosis Following Irradiation and Bone Marrow Transplantation. Am J Resp Cell Mol Biol 38:16-25, 2008.

  70. Li JT, Bonneau LA, Zimmerman JJ, Weiss DJ. Perfluorochemical (PFC) liquid enhances recombinant adenovirus vector-mediated viral interleukin-10 (AdvIL-10) expression in rodent lung. Journal of Inflammation 4:9. 2007.

  71. Petty JM, Sueblinvong V, Lenox CC, Jones CC, Cosgrove JP, Cool CD, Rai PR, Brown KK, Weiss DJ, Poynter ME, Suratt BT, Pulmonary Stromal Derived Factor-1 (SDF-1) expression and effect on neutrophil recruitment during acute lung injury. J Immunology, 178:8148-57, 2007.

  72. Blumen SR, Cheng K, Ramos-Nino ME, Taatjes DJ, Weiss DJ, Landry CL, Mossman BT. Unique Uptake of Acid-Prepared Mesoporous Spheres by Lung Epithelial and Mesothelioma Cells. Am J Respir Cell Mol Biol 36:333-342, 2007

  73. Kostyk AG, Dahl KM, Wynes MW, Whittaker LA, Weiss DJ, Riches DWH. Regulation of macrophage chemokine expression by NaCl occurs independently of cystic fibrosis transmembrane conductance regulator. Am J of Pathology. 169:12-20. 2006

  74. Loi R, Beckett T, Goncz KK, Suratt BT, Weiss DJ. Limited restoration of cystic fibrosis lung epithelium in vivo with adult marrow derived cells. Am J Resp Crit Care Med, 173:171-179. 2006.

    *Article cited as a selected paper in Faculty of 1000 Biology, April 2006 pp.40

  75. Dahlke MH, Loi R, Warren A, Holz L, Popp FC, Weiss DJ, Piso P, Bowen DG, McCaughan GW, Schlitt HJ, Bertolino P. Immune-mediated hepatitis drives low-level fusion between hepatocytes and adult bone marrow cells. J Hepatology, 20:1-8. 2006.

  76. Beckett T, Loi R, Prenovitz R, Poynter ME, Goncz KK, Suratt BT, Weiss DJ. Acute Lung Injury with Endotoxin or NO2 Does Not Enhance Development of Airway Epithelium from Bone Marrow. Molecular Therapy 12:680-686, 2005.

  77. Wang G, Bunnell BA, Painter RG, Tom S, Lanson NA, Spees JL, Bertucci D, Peister A, Weiss DJ, Valentine VG, Prockop DJ, Kolls JK. Adult Stem Cells from Bone Marrow Stroma Differentiate into Airway Epithelial Cells: Potential Therapy for Cystic Fibrosis. Proc Natl Acad Sci. 102(1):186-91 2005.

  78. Trotman W, Beckett T, Goncz KK, Beatty BG, Weiss DJ. Dual Y-Chromosome Painting and In Situ Cell Specific Immunofluorescence Staining in Lung Tissue: An Improved Method of Identifying Donor Marrow Cells in Lung Following Bone Marrow Transplantation. Histochemistry and Cell Biology 121:73-79 2004.

  79. Weiss DJ, Beckett T, Bonneau L, Young J, Kolls JK, Wang G. Transient Increase in Lung Epithelial Tight Junction Permeability: An Additional Mechanism for Enhancement of Lung Transgene Expression by Perfluorochemical Liquids. Molecular Therapy, 8:927-935, 2003

  80. Weiss DJ, Mutlu GM, Bonneau L, Mendez M, Wang Y, Dumasius V, Factor P. Comparison of surfactant and perfluorochemical liquid enhanced adenoviral-mediated gene transfer in normal rat lung. Molecular Therapy 6:43-49 2002.

  81. Weiss DJ, Baskin GB, Shean MK, Blanchard JL, Kolls, JK.Use of perflubron to enhance lung gene expression: Safety and initial efficacy studies in primates. Mol Therapy 5:8-15, 2002.

  82. Weiss DJ, Bonneau L, Liggitt D. Use of perfluorochemical liquid allows earlier detection of gene expression and use of less vector in normal lung and enhances gene expression in acutely injured lung. Molecular Therapy 3:734-745, 2001.

  83. Weiss DJ, Bonneau L, Allen JM, Miller AD, Halbert CL. Perfluorochemical liquids enhance AAV-mediated transgene expression in lung. Molecular Therapy 2:624-630, 2000

  84. Strandjord TP, Madtes DK, Weiss DJ, Sage EH. Collagen accumulation is decreased in SPARC-knockout mice in an intratracheal bleomycin model of pulmonary fibrosis. Am J Physiology 277:L628-635, 1999.

  85. Weiss DJ, Strandjord TP, Liggitt D, Clark JG. Perflubron enhances adenoviral-mediated gene expression in lungs of transgenic mice with chronic alveolar filling. Human Gene Therapy 10:2287-2293, 1999

  86. Weiss DJ, Clark JG, Liggitt D. Use of X-gal at alkaline pH discriminates endogenous b-galactosidase activity from that resulting from exogenous Lac-Z expression. Histochemical Journal 31:231-36, 1999

  87. Weiss DJ, Strandjord TP, Jackson JC, Liggitt D, Clark JG. Perfluorochemical liquid enhanced adenoviral-mediated gene delivery to lungs of spontaneously breathing rodents. Experimental Lung Research 25:317-33, 1999.

  88. Weiss DJ, Liggitt D, Clark JG. Use of the X-gal reagant in demonstrating Lac-Z gene transfer to lung: Assessment of in situ hisotchemical detection of b-galactosidase activity in lung. Human Gene Therapy 8:1545-1554, 1997.

  89. Weiss DJ, Kreck T, Albert RK. Dyspnea resulting from fibromyalgia. Chest 113:246-9, 1997

  90. Weiss DJ, Charles MA, Dunaif A, Prior D, Lillioja S, Knowler W.C, Herman WH: Hyperinsulinemia is associated with menstrual irregularity and altered serum androgens in Pima Indian women. Metabolism 43:803-7, 1994.

  91. Goswami S, Weiss DJ, Gurpide E, Roboz J, Marom Z: Characterization of a unique mucin-like glycoprotein secreted by a human endometrial adenocarcinoma cell line (Ishikawa). Exp Lung Res 20:85-100, 1994.

  92. Weiss DJ, Greenfield Jr. LJW, O'Rourke KS, McCune WJ: Systemic cytomegalovirus infection mimicking an exacerbation of Wegener's granulomatosis. J Rheumatol 20:155-7, 1993.

  93. Weiss DJ, Gurpide E. Characterization of phosphoinositide hydrolysis in a human endometrial adenocarcinoma cell line. Endocrinology 123:981-90, 1988.

  94. Weiss DJ, Gurpide E. Carbachol-stimulated phosphoinositide hydrolysis in a human endometrial adenocarcinoma cell line. Ann NY Acad Sci 494:165-7, 1987.

Peer Reviewed Reviews, Editorials, Statements, Conference Reports, and Letters

82 reports listed most recent to earliest, beginning in 1988

  1. Viswanathan S, Ciccocioppo R, Galipeau J, Krampera M, LeBlanc K, Martin I, Moniz K, Nolta JA, Phinney DG, Shi Y, Szczepiorkowski ZM, Tarte, Weiss DJ, Ashford P.Consensus ICCBBA-ISCT statement on standard nomenclature abbreviations for the tissue of origin of Mesenchymal Stromal Cells.  Cytotherapy, in press 2021.

  2. Wancyk H, Jensen T, Weiss DJ, Finck C.  Advanced Single Cell Technologies to Guide the Development of Bioengineered Lungs.  Am J Physiology in press 2021.

  3. Enes SR, Krasnodembskaya AD, English K, dos Santos CC, Weiss DJ.  Research progress on strategies that can enhance the therapeutic benefits of MSCs in respiratory diseases.  Frontiers in Pharmacology, section Respiratory Pharmacology.  In press 2021.

  4. Enes SR and Weiss DJ.  Bioartificial lungs based on de- and recellularisation approaches: a historical perspective.  European Respiratory Society Breathe  2020  16:  200168;  DOI: 10.1183/20734735.0168-2020.

  5. Abreu SC, Lopes-Pacheco M, Weiss DJ, Rocco PRM. Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Perspectives.  Frontiers Cell and Developmental Biology.  In press 2021.

  6. Weiss DJ; Lim SK; Rohde E; Witwer KW; Giebel B.  Weiss Response to Sengupta et al. (DOI: 10.1089/scd.2020.0095).  Stem Cells & Development. 29(24):1533-1534, 2020.

  7. Khoury M, Ikonomou L, Dominici M, LeBlanc K, Levin BL, Weiss DJ.  The coronavirus pandemic: a pitfall or a fast-track for validating cell therapy products? Stem Cells and Development, in press 12-20.  DOI: 10.1089/scd.2020.0122.

  8. Al Alam D, Ballard PL, Le Saux CJ, Ingram JL, Mariani T, Moore NS, Weiss DJ, Yu M. Human Fetal Tissue Regulation: Impact on Pediatric and Adult Respiratory-Related Research.  Annals of the ATS.  In press 2020.

  9. Enes SR and Weiss DJ.  Bioartificial lung based on de- and recellularization approaches: Historical Perspective.  ERS Educational Publications.  In press 2020.

  10. Ikonomou L, Wagner DE, Gilpin SE, Weiss DJ, Ryan AL.  Technological advances in study of lung regenerative medicine: perspective from the 2019 Vermont lung stem cell conference.  In press Cytotherapy, 2020.

  11. Wagner DE; Ikonomou L; Gilpin SE; Magin CM; Cruz F; Greaney A; Magnusson M; Chen YW; Davis B; Vanuytsel K; Rolandsson Enes S; Krasnodembskaya A; Lehmann M; Westergren-Thorsson G; Stegmayr J; Alsafadi HN; Hoffman ET; Weiss DJ; Ryan AL.  Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease 2019. European Respiratory Journal Open Research. 6(4), 2020.

  12. Cancio M, Ciccocioppo R, Rocco PRM, Levine BL, Bronte V, Bollard CM, Weiss DJ, Boelens JJ, Hanley P. Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapies. Cytotherapy. 2020 May 7:S1465-3249(20)30657-5. doi: 10.1016/j.jcyt.2020.04.100. Online ahead of print.PMID: 32565132.

  13. Borger V; Weiss DJ; Anderson JD; Borras FE; Bussolati B; Carter DRF; Dominici M; Falcon-Perez JM; Gimona M; Hill AF; Hoffman AM; de Kleijn D; Levine BL; Lim R; Lotvall J; Mitsialis SA; Monguio-Tortajada M; Muraca M; Nieuwland R; Nowocin A; O'Driscoll L; Ortiz LA; Phinney DG; Reischl I; Rohde E; Sanzenbacher R; Thery C; Toh WS; Witwer KW; Lim SK; Giebel B.  ISEV and ISCT statement on EVs from MSCs and other cells: considerations for potential therapeutic agents to suppress COVID-19.  Cytotherapy. 2020 May 16.

  14. Lim SK; Giebel B; Weiss DJ; Witwer KW; Rohde E.  Re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19" by Sengupta et al.  In press, Stem Cells & Development. 2020 Jun 10.

  15. Enes SR, Weiss DJ.  Cell Therapy for Lung Disease: Current Status and Future Prospects Journal.  Current Stem Cell Reports,1-10. DOI: 10.1007/s40778-020-00171-5.

  16. Wagner DE, Ikonomou L, Gilpin SE, Magin CM, Cruz F, Greaney AM, Magnusson M, Chen YW, Davis B, Vanuytsel K, Rolandsson Enes S, Krasnodembskaya A, Lehmann M, Westergren-Thorsson G, Stegmayr J, Alfasadi HN, Hoffman ET, Weiss DJ, Firth AL.  Technological Advances in Study of Lung Regenerative Medicine: Perspective from the 2019 Vermont Lung Stem Cell Conference.  Cytotherapy, in press 2020.

  17. Khoury M, Cuenca J, Cruz FF, Figueroa FE, Rocco PRM, Weiss DJ.  Current Status of Cell-Based Therapies for Respiratory Virus Infections.  European Respiratory Journal, in press 2020.

  18. Khoury M, Rocco PRM, Phinney DG, Krampera M, Martin I, Viswanathan S, Nolta JA, LeBlanc K, Galipeau J, Weiss DJ.  Cell-Based Therapies for COVID-19: Proper Clinical Investigations are Essential.  Cytotherapy, in press 2020.

  19. Enes SR, Weiss DJ. Lung Cell Therapy: Current status and future prospects.  In press 2020.

  20. Ikonomou L and Weiss DJ.  Turning the tide on unproven cell-based interventions.  Chest. 2020 Apr;157(4):774-775.

  21. Ryan AL, Ikonomou L, Atarod S, Bölükbas DA, Collins J, Freishtat R, Hawkins F, Gilpin SE, Uhl FE, Uriarte JJ, Weiss DJ, Wagner DE.  Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases 2017. An Official American Thoracic Society Workshop Report.  Am J Respir Cell Mol Biol. 2019 Oct;61(4):429-439. doi: 10.1165/rcmb.2019-0286ST.

  22. Weiss DJ, English K, Krasnodembskaya A, Isaza-Correa JM, Hawthorne IJ, Mahon BP.  The Necrobiology of Mesenchymal Stromal Cells Affects Therapeutic Efficacy.  Front Immunol. 2019 Jun 4;10:1228. doi: 10.3389/fimmu.2019.01228. eCollection 2019. Review.  PMID: 31214185.

  23. de Castro LL, Lopes-Pacheco M, Weiss DJ, Cruz FF, Rocco PRM. Current understanding of the immunosuppressive properties of mesenchymal stromal cells. J Mol Med (Berl). 2019 May;97(5):605-618. doi: 10.1007/s00109-019-01776-y. Epub 2019 Mar 22. PMID: 30903229.

  24. Ikonomou L, Wagner DE, Turner L, Weiss DJ. Translating Basic Research into Safe and Effective Cell-based Treatments for Respiratory Diseases.  Ann Am Thorac Soc. 2019 Jun;16(6):657-668. doi: 10.1513/AnnalsATS.201812-890CME.  PMID: 30917290.

  25. Witwer KW, Van Balkom BWM, Bruno S, Choo A, Dominici M, Gimona M, Hill AF, De Kleijn D, Koh M, Lai RC, Mitsialis SA, Ortiz LA, Rohde E, Asada T, Toh WS, Weiss DJ, Zheng L, Giebel B, Lim SK.  Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications.  J Extracell Vesicles. 2019 Apr 29;8(1):1609206. doi: 10.1080/20013078.2019.1609206.   PMID: 31069028.

  26. Weiss DJ.  Cell-based Therapy for Chronic Obstructive Pulmonary Disease. Rebuilding the Lung.  Ann Am Thorac Soc. 2018 Dec;15(Supplement_4):S253-S259. doi: 10.1513/AnnalsATS.201808-534MG.  PMID: 30759002

  27. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. (one of multiple authors).  J Extracell Vesicles. 2018 Nov 23;7(1):1535750. doi: 10.1080/20013078.2018.1535750. eCollection 2018. PMID: 30637094. PMID: 30637094

  28. Uriarte JJ, Uhl FE, Rolandsson Enes SE, Pouliot RA, Weiss DJ. Lung bioengineering: advances and challenges in lung decellularization and recellularization.  Curr Opin Organ Transplant. 2018 Dec;23(6):673-678. doi: 10.1097/MOT.0000000000000584. PMID: 30300330

  29. Piuzzi NS, Dominici M, Long M, Pascual-Garrido C, Rodeo S, Huard J, Guicheux J, McFarland R, Goodrich LR, Maddens S, Robey PG, Bauer TW, Barrett J, Barry F, Karli D, Chu CR, Weiss DJ, Martin I, Jorgensen C, Muschler GF. Proceedings of the signature series symposium "cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies-promise, facts and fantasy," international society for cellular therapies, Montreal, Canada, May 2, 2018.  Cytotherapy. 2018 Nov;20(11):1381-1400. doi: 10.1016/j.jcyt.2018.09.001. Epub 2018 Oct 10. PMID:30316562.

  30. Caplan A, Badylak SF, Caplan AI, Davies LC, Strömblad S, Weiss DJ, Le Blanc K. Author Accountability in Biomedical Research. Stem Cells Dev. 2018 Nov 20. doi: 10.1089/scd.2018.0214. PMID: 30351188.

  31. Sueblinvong V, Weiss DJ.  Acute Lung Injury: Endothelial Progenitor Cells to the Rescue? Am J Med Sci. 2018 Oct 11. pii: S0002-9629(18)30380-X. doi: 10.1016/j.amjms.2018.10.002.  PMID: 30446164 

  32. Weiss DJ.  Cell-based therapies for acute respiratory distress syndrome. Lancet Respir Med. 2018 Nov 22. pii: S2213-2600(18)30477-6. doi: 10.1016/S2213-2600(18)30477-6. PMID:30473410.

  33. Galipeau J, Weiss DJ, Dominici M. Response to Nature commentary "Clear up this stem-cell mess". Cytotherapy. 2018 Dec 12. pii: S1465-3249(18)30697-2. doi: 10.1016/j.jcyt.2018.11.007. PMID: 30551850.

  34. Weiss DJ, Turner L, Levine AD, Ikonomou L.  Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions. Cytotherapy. 2018 Feb;20(2):165-168. doi: 10.1016/j.jcyt.2017.10.002. Epub 2017 Nov 24.  PMID:29239793.

  35. Silva LHA, Antunes MA, Dos Santos CC, Weiss DJ, Cruz FF, Rocco PRM.  Strategies to improve the therapeutic effects of mesenchymal stromal cells in respiratory diseases.   Stem Cell Res Ther. 2018 Feb 26;9(1):45. doi: 10.1186/s13287-018-0802-8.

  36. Wagner DE, Turner L, Panoskaltsis-Mortari A, Weiss DJ, Ikonomou L. Co-opting of ClinicalTrials.gov by patient-funded studies. Lancet Respir Med. 2018 Jun 19. pii: S2213-2600(18)30242-X. doi: 10.1016/S2213-2600(18)30242-X. PMID: 29934051  

  37. Weiss DJ, Cruz FF, Rocco PRM.  hMSCs as an alternative therapeutic option for asthma with neutrophil mediated inflammation,  Letter to the Editor.  Experimental & Molecular Medicine.  In press 2018.

  38. Silva LH, Antunes Mam dos Santos CC, Weiss DJ, Cruz FF, Rocco PRM.  Strategies to improve the therapeutic effects of mesenchymal stromal cells in respiratory diseases.  Stem Cell Research & Therapy in press 2018.

  39. Ikonomou L, Panoskaltsis-Mortari A, Wagner DE, Freishtat RJ, Weiss DJ; American Thoracic Society Respiratory Cell and Molecular Biology Assembly Stem Cell Working Group. Unproven Stem Cell Treatments for Lung Disease-An Emerging Public Health Problem. Am J Respir Crit Care Med. 2017 Apr 1;195(7):P13-P14. doi: 10.1164/rccm.1957P13. No abstract available. PMID: 28362195

  40. Srivastava A, Mason C, Wagena E, Cuende N, Weiss DJ, Horwitz EM, Dominici M. Part 1: Defining unproven cellular therapies. Cytotherapy. 2016 Jan;18(1):117-9.

  41. Weiss DJ, Rasko JE, Cuende N, Ruiz MA, Ho HN, Nordon R, Wilton S, Dominici M, Srivastava A.  Part 2: Making the "unproven" "proven".  Cytotherapy. 2016 Jan;18(1):120-3. 

  42. Cruz FF, Weiss DJ, Rocco PR.  Prospects and progress in cell therapy for acute respiratory distress syndrome.  Expert Opin Biol Ther. 2016 Nov;16(11):1353-1360.

  43. Ikonomou L, Freishtat RJ, Wagner DE, Panoskaltsis-Mortari A, Weiss DJ. The Global Emergence of Unregulated Stem Cell Treatments for Respiratory Diseases. Professional Societies Need to Act.  Ann Am Thorac Soc. 2016 Aug;13(8):1205-7.

  44. Abreu SC, Weiss DJ, Rocco PR.  Extracellular vesicles derived from mesenchymal stromal cells: a therapeutic option in respiratory diseases?   Stem Cell Res Ther. 2016 Apr 14;7(1):53.

  45. Wagner DE, Cardoso WV, Gilpin SE, Majka S, Ott H, Randell SH, Thébaud B, Waddell T, Weiss DJ; ATS Subcommittee on Stem Cells and Cell Therapies. An Official American Thoracic Society Workshop Report 2015. Stem Cells and Cell Therapies in Lung Biology and Diseases.  Ann Am Thorac Soc. 2016 Aug;13(8):S259-78.

  46. Dominici M, Nichols K, Srivastava A, Weiss DJ, Eldridge P, Cuende N, Deans RJ, Rasko JE, Levine AD, Turner L, Griffin DL, O'Donnell L, Forte M, Mason C, Wagena E, Janssen W, Nordon R, Wall D, Ho HN, Ruiz MA, Wilton S, Horwitz EM, Gunter KC; 2013–2015 ISCT Presidential Task Force on Unproven Cellular Therapy.  Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective.  Cytotherapy. 2015 Dec;17(12):1663-6

  47. Antunes MA, Weiss DJ, Rocco PRM.  Mesenchymal stromal cells in chronic respiratory diseases: What’s New?  Physiological Mini Reviews.  In press 2015.

  48. Weiss DJ and LeBlanc K.  Cell Therapies for ARDS: The Importance of Proper Study Design-Letter to the Editor-in-Chief and his Response.  Journal of Stem Cell Research and Therapy.  In press 2015

  49. Weiss DJ, Chambers D, Giangreco A, Keating A, Kotton D, Lelkes PI, Wagner DE, Prockop DJ; ATS Subcommittee on Stem Cells and Cell Therapies.  An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases.  Ann Am Thorac Soc. 2015 Apr;12(4):S79-97

  50. Weiss DJ. Cell therapies for ARDS: a promising start. Lancet Respir Med 3(1): 2-3, 2015.

  51. Weiss DJ, Chamber D, Janes S, Morales M, Thebaud B.  Cell Therapies for Pulmonary Diseases and Critical Illnesses: A New Frontier.  ISCT Bulletin.  In press 2014.

  52. Weiss DJ, Elliot M, Jang Q, Poole B, Birchall M. Tracheal Bioengineering: The Next Steps. Proceeds of an International Society of Cell Therapy. Pulmonary Cellular Therapy Signature Series Workshop, Paris France. Cytotherapy 16(12): 1601-13, 2014.

  53. Liles WC, Matthay MA, dos Santos CC, Weiss DJ, Stewart DJ.  Mesenchymal Stromal (Stem) Cell Therapy: An Emerging Immunomodulatory Strategy for the Adjunctive Treatment of Sepsis.  Letter to the editor. Am J Resp Crit Care Med,189(3): 363-4, 2014.

  54. Viswanathan S, Keating A, Deans R, Hematti P, Prockop DJ, Stroncek D, Stacey G, Weiss DJ, Mason C, Rao M. Soliciting Strategies for Developing Cell-Based Reference Materials to Advance MSC Research and Clinical Translation.  Stem Cells and Development.  Stem Cells Dev 23(11): 1157-67, 2014.

  55. Weiss DJ.  Current Status of Stem Cells and Regenerative Medicine in Lung Biology and Diseases.  Stem Cells. 32(1):16-25, 2014.

  56. Matthay MA, Anversa P, Bhattacharya J, Burnett BK, Chapman HA, Hare JM, Hei DJ, Hoffman AM, Kourembanas S, McKenna DH, Ortiz LA, Ott HC, Tente W, Thebaud B, Trapnell BC, Weiss DJ, Yuan XJ, Blaisdell CJ.  Cell Therapy for Lung Diseases. Report from an NIH–NHLBI Workshop, November 13–14, 2012.  American Journal of Respiratory and Critical Care Medicine, Vol. 188, No. 3, August 1, 2013: 370-375.

  57. Weiss DJ.  Stem Cells, Cell Therapies and Bioengineering in Lung Biology and Diseases: Comprehensive Review of the Literature.  Annals of the American Thoracic Society. 10(5):S45-97, 2013.

  58. Report from a UK-U.S.-Canada led Workshop March 2013. (One of multiple authors).  Building towards a Standard for MSC’s: A. In press Stem Cells, 2013.

  59. Weiss DJ, Ortiz LA.  Invited Editorial: Cell Therapy Trials for Lung Diseases: Progress and Cautions.  American Journal of Respiratory and Critical Care Medicine 188(2):123-125, 2013.

  60. Weiss DJ, Bates JHT, Gilbert T, Liles WC, Lutzko C, Rajagopal J, Prockop DJ. Vermont Stem Cell Conference Report: Stem Cells and Cell Therapies in Lung Biology and Diseases. Annals of the American Thoracic Society. 10(5):S25-44, 2013.

  61. Wagner DE, Bonvillain RW, Jensen T, Girard ED, Bunnell BA, Finck CM, Hoffman AM, Weiss DJ. Can Stem Cells be used to Generate New Lungs? Ex Vivo Lung Bioengineering with Decellularized Whole Lung Scaffolds.  Respirology 18(6):895-911, 2013.

  62. Lau A, Goodwin M, Kim C, Weiss DJ. Advances in Stem Cells and Cell Therapies for Lung Biology and Diseases. Molecular Therapy: the Journal of the American Society of Gene Therapy. 20(6):1116-30, 2012.

  63. Badylak SF, Weiss DJ, Caplan A, Macchiarini P. Engineered whole organs and complex tissues. Lancet 379(9819):943-52, 2012.

  64. Weiss DJ, Bertoncello I, Borok Z, Kim C, Panoskaltsis-Mortari A, Reynolds S, Rojas M, Stripp B, Warburton D, Prockop DJ.  Stem Cells and Cell Therapies in Lung Biology and Lung Diseases: Vermont Stem Cell Conference Report.  Proceedings of the American Thoracic Society 8(3):223-72, 2011.

  65. Moodley Y, Manuelpillai U, Weiss DJ.  Cellular Therapies for Lung Disease-A Distant Future?  Respirology 16(2):223-37, 2011.

  66. Grove D, Weiss DJ, Sueblinvong V.  Mesenchymal stem cells: promise for chronic obstructive pulmonary disease therapy?  Therapy  6:1-4  2010.

  67. Sueblinvong V, Weiss DJ.   Stem cells and cell therapy approaches in lung biology and diseases. Translational Research: The Journal of Laboratory & Clinical Medicine. 156(3):188-205, 2010.

  68. Panoskaltsis-Mortari A and Weiss DJ.  Breathing new life into lung transplantation therapy.  Mol Therapy 18(9):1581-3, 2010.

  69. Finck CM and Weiss DJ.  Embryonic stem cells and repair of lung injury.  Mol Therapy, 18(3):460-1, 2010.

  70. Sueblinvong V and Weiss DJ.  Cell therapy approaches for lung diseases: current status.  Current Opinion in Pharmacology. 9(3):268-73, 2009.

  71. Keating A et al (Weiss DJ).  NHLBI Working Group: Enhancing Translational Research and Early Phase Trials for Cellular Therapy. 2009 http://www.nhlbi.nih.gov/meetings/workshops/enhance-cell-therapy-exesum.htm

  72. Weiss DJ.  Intersection of gene therapy and progenitor cell biology in the lung.  Molecular Therapy. 17(2):214-6, 2009.

  73. Weiss DJ.  Stem cell therapies draw nearer to rebuilding patients lungs.  Pulmonary Reviews.  13:1-17. 2008.

  74. Weiss DJ, Kolls JK, Ortiz LA, Panoskaltis-Mortari A, Prockop DJ.  Stem Cells and Cell Therapy Approaches for Lung Diseases.  Vermont Stem Cell Conference Report.    Proc Am Thoracic Society, 5:637-667. 2008.

  75. Weiss DJ. Stem Cells and Cell Therapies for Cystic Fibrosis and Other Lung Diseases.  Pulmonary Pharmacology & Therapeutics. 21(4):588-94, 2008.

  76. Sueblinvong V, Suratt BT, Weiss DJ.  Update in Gene and Stem Cell Therapies for Cystic Fibrosis.  Clinics in Chest Medicine.  28:361-380. 2007.

  77. Brown JK, Ewart G, Hogan BLM, Neubauer J, Randell SH, Stripp B, Weiss DJ.  Against the ATS statement on human embryonic stem  cell research: letter response.  Am J Resp Crit Care Med, 174:357-8.  2006.

  78. Brown JK, Hogan BLM, Randell SH, Stripp B, Weiss DJ. Human Embryonic Stem Cell Research: An Official ATS Research Policy Statement. Am J Resp Crit Care Med 173:1-3.  2006.

  79. Weiss DJ, Berberich MA, Borok Z, Gail D, Kolls JK, Penland C, Prockop DJ.  National Heart Lung Blood Institute/Cystic Fibrosis Foundation Workshop Report Adult Stem Cells, Lung Biology, and Lung Disease.  Proceedings of the American Thoracic Society, 3:193-207.  2006.

  80. Weiss DJ, Pilewski J.  Current Status of Gene Therapy for Cystic Fibrosis.  Seminars in Pulmonary and Critical Care Medicine 24:749-770 2003.

  81. Weiss DJ.  Delivery of Gene Transfer Vectors to Lung: Obstacles and the Role of Adjunct Techniques for Airway Administration.  Molecular Therapy 6:148-152 2002.

  82. Weiss DJ, Gurpide E.  Non-genomic effects of estrogens and anti-estrogens. Steroid Biochem 31:671-6, 1988.

Selected Research Abstracts

99 abstracts listed most recent to earliest, beginning in 1998

  1. Jorge Otero, Bryan Falcones, Robert A. Pouliot, Juan J. Uriarte, Daniel J. Weiss, Daniel Navajas, Ramon Farre. “Physical properties of bioprinted hydrogel structures based on decellularized porcine lungs for 3D cell culture”. 2018 TERMIS World Congress, Kyoto, Japan.

  2. Franziska E. Uhl, Robert R. Pouliot, Juan J. Uriarte, Xinyue Liu, Xiaorui Han, Fuming Zhang, Robert J. Linhardt, Daniel J. Weiss, “Characterization of glycoproteins in decellularized lung tissue and their role for bioengineering of transplantable organs” Biologic Scaffolds for Regenerative Medicine Symposium, Napa USA (2018)

  3. Juan J. Uriarte, Hee-Eon Park, Franziska E. Uhl, Sean M. Wrenn, Ethan D. Griswold, Jacob S. Dearborn, Bethany A. Ahlers, B. Deng, Y.W. Lam, Dryver Huston, Patrick C. Lee, Darcy E. Wagner, Daniel J. Weiss, “De- and Recellularization of Avian Lungs: A Novel Scaffold for Lung Bioengineering”, Biologic Scaffolds for Regenerative Medicine Symposium, Napa USA (2018)

  4. Juan J. Uriarte, Hee-Eon Park, Franziska E. Uhl, Sean M. Wrenn, Ethan D. Griswold, Jacob S. Dearborn, Bethany A. Ahlers, B. Deng, Y.W. Lam, Dryver Huston, Patrick C. Lee, Darcy E. Wagner, Daniel J. Weiss, “De- and Recellularization of Avian Lungs: Exploring New Frontiers for Lung Bioengineering” Annual conference of the ATS, San Diego, USA (2018)

  5. Franziska E. Uhl, Robert R. Pouliot, Juan J. Uriarte, Fuming Zhang, Robert J. Linhardt, Daniel J. Weiss, “Glycoproteins in decellularized lung tissues – Novel insights into their role for bioengineering of transplantable organs” Annual conference of the ATS, San Diego, USA (2018)

  6. Franziska E Uhl, Barbora Zvarova, Julia G Fields, Bethany A Ahlers, Catrina M Hood, Bin Deng, Ying Wai Lam, Erica Beatman, Kelly S. Schweitzer, Irina Petrache, Daniel J Weiss, Darcy E Wagner, “Identification of potential treatment targets for COPD by mass spectrometry-based proteomics”, Lung Science Conference, Estoril, Portugal, (2018)

  7. Sean M. Wrenn, Ethan D. Griswold, Franziska E. Uhl, Amy L. Coffey, Jacob S. Dearborn, R.J. Hommel, Ying-Wai Lam, Bin Deng, Bethany A. Ahlers, Darcy E. Wagner, Daniel J. Weiss, “Avian Lung Bioengineering” Annual conference of the ATS, Washington DC, USA (2017)

  8. R.A. Pouliot, J.K. Kittel, F.E. Uhl, J.J. Uriarte, D. J. Weiss, “A Cheap, Modular, 3D Bioprinter for Producing Living in-vitro Models”. Vermont Stem Cell Conference, Burlington, VT, USA (2017)

  9. S.M. Wrenn, E.D. Griswold, F.E. Uhl, J.J. Uriarte, H.E. Park, A.L. Coffey, J.S. Dearborn, R.J. Hommel, Y.W. Lam, B. Deng, B.A. Ahlers, P.C. Lee, D. R. Huston, D.E. Wagner, D.J. Weiss, “Lung Bioengineering using Avian Tissue”. Vermont Stem Cell Conference, Burlington, VT, USA (2017)

  10. A.K. Riveron, N. Gasek, Z. Phillips, F.E. Uhl, L. Fabricant, D.J. Weiss, “Development of Biologically-Inspired Pleural Sealants”. Vermont Stem Cell Conference, Burlington, VT, USA (2017)

  11. A.L. Thiebes, F.E. Uhl, J.S. Dearborn, C.G. Cornelissen, S. Jockenhoevel, D.J. Weiss, “Aerosolization of Mesenchymal Stem Cells for Cell Therapy Approaches”. Vermont Stem Cell Conference, Burlington, VT, USA (2017)

  12. F.E Uhl, B. Zvarova, J.G. Fields, B.A. Ahlers, B. Deng, Y.W. Lam, E. Beatman, K. Schweitzer, I. Petrache, D.J. Weiss, D.E. Wagner, “Mass spectrometry-based proteomics identified differences in protein compositions of acellular emphysematous versus normal lungs: Revelation of potential treatment targets?”. Vermont Stem Cell Conference, Burlington, VT, USA (2017)

  13. Cruz FF, Oliveira HG, Antnes MA, Neto AVD, Oliveira GA, Svartman FM, Rebelatto CLK, Weiss DJ, Brffman PRS, Rocco PRM. A Placebo-Controlled, Randomized Trial of Mesenchymal Stem Cells Associated with One-Way Endo-Bronchial Valves in Severe COPD Patients. Annual conference of the ATS, San Francisco, USA (2016)

  14. F.E. Uhl, B. Zvarova, J.G. Fields, B. Deng, Y.W. Lam, D.J. Weiss, D.E. Wagner, “Enhanced Mass Spectrometry-Based Proteomics Can Be Used To Distinguish Differences In Protein Compositions Of Acellular Emphysematous Versus Normal Lungs”. Annual conference of the ATS, San Francisco, USA (2016)

  15. S.M. Wrenn, A.L. Coffey, F.E. Uhl, J. Bianchi, B. Dacken, T. Petersen, D.E. Wagner, J. Boysona, D.J. Weiss, “Decellularized Wild Type and α-Galactosyltransferase Knockout Pig Lungs Stimulate M2 Phenotype in Human Monocyte/Macrophages”. Annual conference of the ATS, San Francisco, USA (2016)

  16. F.E. Uhl, R. Costa, B. Zvarova, J.G. Fields, B. Deng, Y.W. Lam, M. Königshoff, D.J. Weiss, D.E. Wagner, “Acellular emphysematous lungs retain pathophysiological attributes and can be used as a novel in vitro culture system for studying disease biology”, DZL annual meeting, Hannover, Germany (2016)

  17. J. Platz, N.R. Bonenfant, F.E. Uhl, A.L. Coffey, T. McKnight, C. Parsons, D. Sokocevic, Z.D. Borg, Y.W. Lam, B. Deng, J.G. Fields, M. DeSarno, R. Loi, A.M. Hoffman, J. Bianchi, B. Dacken, D.E. Wagner, D.J. Weiss, “Comparative Decellularization and Recellularization of Wild Type and Alpha 1,3 Galactosyltransferase Knockout Pig Lungs: A Model for Ex Vivo Xenogeneic Lung Bioengineering and Transplantation”. Annual conference of the ATS, San Francisco, USA (2016)

  18. J Pothen, V. Rajendarn, D.E. Wagner, DJ Weiss, B.J. Smith, B. Ma, J Bates. “A computational model of cellular engraftment on lung scaffolds” Vermont Stem Cell Conference: Stem Cells and Cell Therapies in Lung Biology and Lung Disease” (2015)

  19. F.E. Uhl, B. Zvarova, J.G. Fields, B. Deng, Y.W. Lam, D.J. Weiss, D.E. Wagner, “Acellular emphysematous lungs retain pathophysiological attributes and can be used as a novel in vitro culture system for studying disease biology”. Munich Pittsburgh Lung Conference, Munich, Germany (2015)

  20. Cruz, F, Borg Z, Goodwin M, Coffey A, Wagner D, Sokocevic D, Rocco PRM, Weiss DJ. CD11b and SCa-1-Positive Cells Exert the Main Beneficial Effects of Bone Marrow-Derived Mononuclear Cell Therapy in a Murine Model of Sever Asthma. Annual conference of the ATS, Denver, USA (2015)

  21. Uhl FE, Zvarova B, Ganister Fields J, Deng B, Wai Lam Y, Weiss DJ, Wagner DE “Enhanced mass spectrometry proteomics can be used to distinguish differences in protein compositions of acellular emphysematous versus normal lungs” North East Regional Life Sciences Core Directors (October 2015)

  22. B. Zvarova, F.E. Uhl, N.R. Bonenfant, J.J. Uriarte, W. Chia, Z. Borg, D.J. Weiss, D.E. Wagner, “Residual Detergent Detection and Cell Viability Testing in Decellularized Whole Lungs”. Annual conference of the ATS, Denver, USA (2015)

  23. Cruz, F, Borg Z, Sokocevic D, Wagner D, Goodwin M, Rocco PRM, Weiss DJ. Bone Marrow-Derived Mononuclear Cells, Human MSCs, And Freshly Thawed MSCs Ameliorate Aspergillus Hyphal Extract-Induced Allergic Airways Inflammation In Immunocompetent Mice. American Thoracic Society International Conference, 2014, San Diego CA.

  24. Pothen J, Rajendran V, Wagner D, Weiss DJ, and Bates J. Agent-based models for studying stem cell dynamics on decellularized lung scaffolds. Presented at Biomedical Engineering Society Meeting, San Antonio TX, October 2014.

  25. Loi R, Pinna S, and Weiss DJ. Derivation of normal and cystic fibrosis human induced pluripotent stem cells (iPSCs) from airway epithelium. Abstract presented at the 36th European Cystic Fibrosis Conference, 12-15 June, 2013, Lisbon, Portugal

  26. Goodwin M, Daly A, Weiss DJ. A29. Stem Cells: Who Are You, How Can You Help Me, and What Do You Need? Poster presented at the 2011 American Thoracic Society (ATS) in Denver Colorado

  27. Goodwin M, Weiss DJ. EPCs, MSCs, and Cell Therapy Approaches for Lung Diseases. Abstract presented at the 2011 Vermont Stem Cell Meeting, “Stem Cells and Cell Therapies in Lung Biology and Lung Diseases”

  28. Daly A, Wallis JM, Borg ZD, Bonvillain R, Deng B, Ballif BA, Jaworski DM, Allen GB, and Weiss DJ. Initial Binding and Subsequent Re-Cellularization of 3-Dimensional De-Cellularized Mouse Lung Scaffolds with Bone Marrow-Derived Mesenchymal Stromal Cells. Abstract presented at the 2011 Vermont Stem Cell Meeting, “Stem Cells and Cell Therapies in Lung Biology and Diseases”.

  29. Lathrop M, Macura SL, Mossman B, Weiss DJ. Mesenchymal stromal cells exert anti-inflammatory and anti-tumorigenic properties which alter the tumor microenvironment of malignant mesothelioma. Abstract presented at the 2011 Vermont Stem Cell Meeting, “Stem Cells and Cell Therapies in Lung Biology and Diseases”.

  30. Wallis J, Borg ZD, Daly AB, Deng B, Ballif BA, Jaworski DM, Allen GB, Weiss DJ. Optimizing De-Cellularization and Re-cellularization of Whole Mouse Lung Scaffolds: A Comparative Methods Study. Abstract presented at the 2011 Vermont Stem Cell Meeting, “Stem Cells and Cell Therapies in Lung Biology and Diseases”.

  31. Wangensteen L, Lathrop M, Daly A, Borg Z, Weiss DJ. Identification of human mesenchymal stromal cells recovered from human bronchoalveolar lavage (BAL) fluid using CD146+/CD45- selection. Abstract presented at the 2011 Vermont Stem Cell Meeting, “Stem Cells and Cell Therapies in Lung Biology and Diseases”.

  32. Wallis J, Borg ZD, Daly AB, Deng B, Ballif BA, Weiss DJ Re-Cellularization of 3-Dimensional De-Cellularized Human Lung Scaffolds with Bone Marrow-Derived Mesenchymal Stromal Cells. Abstract presented at the 2011 Vermont Stem Cell Meeting, “Stem Cells and Cell Therapies in Lung Biology and Diseases”.

  33. Gil S, Weiss DJ, and Matute-Bello G. Resident murine lung mesenchymal stromal cells modulate response to acute inflammatory lung injury in a strain-dependent manner. Abstract presented at the American Thoracic Society (ATS) annual meeting Denver 2011.

  34. Daly A, Goodwin M, Sueblinvong V, Panoskaltsis-Mortari A, Weiss DJ. MSCs Spontaneously Express Pro-SPC When Cultured in Intact De-Cellularized Mouse Lungs. Abstract presented at the American Thoracic Society (ATS) annual meeting New Orleans 2010.

  35. Candon J, Jaworski DM, von Reyn JA, Cloutier ME, Bates JHT, Weiss DJ, Allen GB. TIMP-2 null mice have lower pulmonary impedance compared to weight-matched controls at baseline and following lung injury. Abstract presented at the American Thoracic Society (ATS) annual meeting New Orleans 2010.

  36. Bozyk PD, Popova AP, Bentley JK, Goldsmith AM, Spees JL, Phan SH, Weiss DJ, Hershenson MB. MESENCHYMAL STEM CELLS FROM NEONATAL TRACHEAL ASPIRATES DEMONSTRATE A PATTERN OF GENE EXPRESSION CONSISTENT WITH A LUNG ORIGIN. Abstract presented at the American Thoracic Society (ATS) annual meeting New Orleans 2010.

  37. Goodwin M, Daly A, Sueblinvong V, Weiss DJ. Mesenchymal Stem Cells Abrogate Allergic Airways Disease by Presenting Antigen To CD4 Lymphocytes and Promoting a Th1 Phenotype. Abstract presented at the American Thoracic Society (ATS) annual meeting New Orleans 2010.

  38. Goodwin M, Daly A, Sueblinvong V, Weiss DJ. Mesenchymal Stem Cells Abrogate Allergic Airways Disease by Presenting Antigen To CD4 Lymphocytes and Promoting a Th1 Phenotype. Abstract presented at the 3rd Biennial IDeA Symposium, Washington DC 2010.

  39. Goodwin M, Daly A, and Weiss DJ. Systemic Administration of Mesenchymal Stromal Cells Inhibits Th2-Mediated Allergic Airways Inflammation in Mice. Abstract presented at the New England Stem Cell Consortium UVM 2010.

  40. Goodwin M, Daly A, Sueblinvong V, Weiss DJ. Mesenchymal Stem Cells Abrogate Allergic Airways Disease by Presenting Antigen To CD4 Lymphocytes and Promoting a Th1 Phenotype. Abstract presented at the American Thoracic Society (ATS) annual meeting. New Orleans 2010.

  41. Goodwin M, Eisenhauer PL, Sueblinvong V, Weiss DJ. Mesenchymal Stem Cells Suppress Allergic Airways Disease and Improve Lung Function Through a Mechanism Independent of CD4+ Lymphocyte Proliferation. Abstract presented at the FASEB Summer Research Conference on Lung Epithelium in Development and Disease. Saxtons River, Vermont July 2009.

  42. Goodwin M, Eisenhauer PL, Sueblinvong V, Weiss DJ. Systemic Administration of Murine Mesenchymal Stem Cells Abrogates Allergic Airways Inflammation. Abstrwact presented at the 6th International Society for Stem Cell Research Annual Meeting Abstract #: 315

  43. Goodwin M, Eisenhauer PL, Sueblinvong V, Weiss DJ. Systemic Administration of Mesenchymal Stem Cells Abrogates Allergic Airways Inflammation by Inhibiting CD4 T Cell Th2 Phenotype Development. Abstract presented at the ATS/ALA Meeting, 2009.

  44. Sueblinvong V, Larsen ER, Spees JL, Weiss DJ. Three-Dimensional Culture Systems Can Induce Lung Epithelial Cells Markers Expression by Mesenchymal Stem Cells In Vitro. Abstract presented at the ATS/ALA Meeting, May 2008.

  45. Sueblinvong V, Wang D, Wetsel RA, Weiss DJ. Human Embryonic Stem Cells Can Acquire Airway Epithelial Cell Phenotype In Vitro. Abstract presented at the ATS/ALA Meeting, May 2008.

  46. Entezari-Zaher T, Weiss DJ, Gangisetti S, Caryl M, Miller E, Tracey KJ, Wang H, Mantell L. The role of HMGB1 in the pathogenesis of cystic fibrosis. Abstract presented at the ATS/ALA Meeting, May 2008.

  47. Goodwin MA, Eisenhauer PL, Sueblinvong V, Weiss DJ. "Systemic Administration of Mesenchymal Stem Cells Abrogates Allergic Airways Inflammation" Abstract presented at the ATS/ALA Meeting, May 2008.

  48. Goodwin MA, Eisenhauer PL, Sueblinvong V, Weiss DJ. “Allogeneic Transplant of Mesenchymal Stem Cells Decrease Th2-mediated Inflammation in Lung” Vermont Stem Cell Meeting, August 2007.

  49. Sueblinvong V, Eisenhauer PL, Bernstein IM, Spees JL, Weiss DJ. Cord Blood-Derived Mesenchymal Stem Cells Can Participate in Lung Epithelial Remodeling In Vivo. Abstracted presented at 2007 Aspen Lung Conference, Aspen, CO.

  50. Sueblinvong V, Eisenhauer PL, Bernstein IM, Spees JL, Weiss DJ. Cord Blood-Derived Mesenchymal Stem Cells Can Participate in Lung Epithelial Remodeling In Vivo. Abstract presented at 2007 American Thoracic Society/American Lung Association meeting, San Francisco, CA. Am J Resp Crit Care Med. April 2007;175: A762.

  51. Sueblinvong V, Eisenhauer P, Bernstein I, Spees J, Weiss DJ. Cord Blood-Derived Mesenchymal Stem Cells Can Participate in Lung Epithelial Remodeling In Vivo. Abstract presented at the 2007 ATS/ALA meeting, San Francisco. Am J Resp Crit Care Med. April 2007;175.

  52. Sueblinvong V, Loi R, Jaskolka JR, Poynter ME, Suratt BT, Weiss DJ. IL-17 and SDF-1 Mediate Recruitment of Cord Blood Stem Cells to Lung Epithelium. Abstract presented at North America Cystic Fibrosis Conference, Nov 2006, Denver, CO. Pediatric Pulmonology. Supplement 29, 2006; 302.

  53. Sueblinvong V, Loi R, Poynter ME, Bernstein IM, Weiss DJ. Development of Lung Epithelium from Cord Blood Stem Cells. Abstract presented at 2006 American Thoracic Society/American Lung Association meeting, San Diego, CA. Proceedings of the American Thoracic Society. April 2006;3:A25.

  54. Sueblinvong V, Loi R, Jaskolka JR, Poynter ME, Suratt BT, Weiss DJ IL-17 and SDF-1 Mediate Recruitment of Cord Blood Stem Cells to Lung Epithelium. Abstract presented at the 2006 North American Cystic Fibrosis Conference, Denver. Pediatric Pulmonology Supplement 29, 2006.

  55. Sueblinvong V, Weiss DJ. Development of airway epithelium form cord blood stem cells. Abstract presented at the 2006 ATS/ALA meeting, San Diego. Proceedings of the American Thoracic Society April 2006.

  56. Loi R, Prenovitz R, Sueblinvong V, Davis GS, Weiss DJ. Lung injury by silica inhalation does not enhance recruitment of bone marrow-derived cells to lung epithelium. Abstract presented at Adult Stem Cells, Lung Biology, and Lung Disease Conference, July 2005, Burlington, VT. Proceedings of the American Thoracic Society 3:193, 2006.

  57. Loi R, Beckett T, Goncz KK, Suratt BT, Weiss DJ. Limited restoration of defective cystic fibrosis lung epithelium in vivo with adult marrow-derived cells. Abstract presented at the 2005 North American Cystic Fibrosis Conference, Baltimore. Pediatric Pulmonology Supplement 28:250, 2005.

  58. Popp FC, Loi R, Inoue S, Piso P, Geissler EK, Weiss DJ Schlitt HJ, Bertolino P, Dahlke M. Fusion of bone marrow cells with resident hepatocytes occurs under regenerative conditions in inflammatory liver disease. Abstract presented at the 2005 International Society for Stem Cell Research meeting, San Francisco.

  59. Loi R, Jaskolka J, Prenovitz R, You Y, Brody SL, Weiss DJ. IL-17 Induces Migration of Adult Marrow Stromal Cells to Lung Epithelium. Mol Therapy 11:S139, 2005.

  60. Beckett T, Lundblad LA, Lala D, Davis GS, Bates JHT, Weiss DJ. Caloric restriction and subsequent re-feeding in mice results in corresponding reversible changes in lung structure, function and volume but no change in pro-SPC-containing cells. Proc American Thoracic Society 2:A286, 2005.

  61. Loi R, Jaskolka J, Prenovitz R, You Y, Brody SL, Weiss DJ. Release of soluble mediators by primary cultured mouse tracheal epithelial cells induces migration of stromal bone marrow cells. Proc American Thoracic Society 2:A283, 2005.

  62. Goncz KK, Loi R, Beckett T, Prenovitz R, Weiss DJ. CFTR mRNA is Expressed in Lungs of CFTR-KO Mice Loi R, Beckett T, Goncz KK, Poynter ME, Suratt BT, Weiss DJ. Development of Lung Airway Epithelium In Vivofrom Adult Marrow-Derived Cells: Fact and Fiction. Abstract presented at the 4th Annual Conference onMesenchymal and Non-Hematopoetic Stem Cells, October 2004, New Orleans, LA.

  63. Wang G, Bunnell BA, Painter RG, Tom S, Lanson NA, Spees JL, Bertucci D, Weiss DJ, Valentine VG, Prockop DJ, Kolls JK. Potential of bone marrow mesenchymal stem cells for cystic fibrosis therapy. Mol Therapy 9:A514, 2004.

  64. Goncz KK, Loi R, Beckett T, Prenovitz R, Weiss DJ. CFTR mRNA is Expressed in Lungs of CFTR-KO Mice Following Administration of Adult Marrow Cells from Wild-Type Donor Mice. Mol Therapy 9:A691, 2004.

  65. Beckett T, Lundblad LKA, Bates JHT, Stern M, Weiss DJ. Caloric restriction and subsequent re-feeding results incorresponding reversible changes in lung structure and function in mice. Am J Resp Crit Care Med 169:A273, 2004.

  66. Beckett T, Trotman W, Prenovitz R, van Hoek M, Goncz KK, Poynter M, Robbins J, Suratt BT, Weiss DJ. Effect of Different Lung Injuries on Recruitment of Bone Marrow Cells to Lung. Am J Resp Crit Care Med 169:A212, 2004.

  67. Beckett T, Goncz KK, Poynter M, Suratt BT, Grove J, Krause DS, Weiss DJ. Repopulation of CFTR-KO mouse lung epithelium with bone marrow-derived cells: Effect of different models of lung injury. Pediatric Pulmonology Supp 25:A235, 2003.

  68. Beckett T, Poynter M, Robbins J, Prenovitz R, van Hoek M, Suratt B, Goncz KK, Weiss DJ. Recruitment of Bone Marrow Cells to Lung Following Clinically Relevant Lung Injuries. Abstract presented at the 3rd Annual Conference on Mesenchymal and Non-Hematopoetic Stem Cells, New Orlean LA.

  69. Weiss DJ, Goncz KK, Beckett T, Poynter M, Suratt BT, Krause DS. Re-population of normal and injured CFTR-KO mouse lung epithelium with bone-marrow derived cells. Abstract presented at the International Society for Stem Cell Research Meeting, Washington DC June 2003.

  70. Trotman W, Goncz KK, Beckett T, Beatty B, Weiss DJ. Improved method for co-localization of cell specific immunohistochemical markers with the FISH detection of the Y-chromosome in lung epithelium. Abstract presented at the International Society for Stem Cell Research Meeting, Washington DC June 2003.

  71. Beckett T, Poynter ME, Weiss DJ. Adenovirus-Mediated Viral Interleukin-10 (AdvIL-10) Expression Mitigates Oxygen Radical Mediated Injury in Lung Epithelial Cells. Molecular Therapy 7:S385 2003.

  72. Goncz KK, Beckett T, Poynter ME, Gruenert DC, Krause DS, Weiss DJ. Comparison of Lung Injury Models for Re-population of CFTR-KO Mouse Lung Epithelium with Bone-Marrow Derived Cells. 2003 Am Soc of Gene Therapy Meeting, June 2003.

  73. Weiss DJ, Goncz KK, Poynter M, Beckett T, Gruenert DC. Re-population of CFTR-KO Mouse Lung Epithelium with Bone-Marrow Derived Cells. Am J Resp Crit Care Med 167:A163 2003.

  74. Goncz KK, Weiss DJ, Beckett T. Gruenert DC. Potential Enhancement of SFHR-Mediated Modification of the CFTR Gene In Vivo by Perfluorochemical Liquid. Ped Pulmonology Suppl. 24:A219, 2002.

  75. Weiss DJ, Bonneau L, Liggitt D. Inhalation of Nebulized Perflubron Enhances Adenovirus Mediated Gene Expression in Lung Epithelium. Molecular Therapy 5:S68 2002.

  76. Weiss DJ, Bonneau L, Liggitt D. Instillation of Perfluorochemical (PFC) Liquid to Lungs of Spontaneously breathing Rodents Transiently Opens Tight Junctions Between Airway Epithelial Cells: A Possible Mechanism for Enhancement of Gene Expression Using PFC Liquids. Mol Therapy 3:A952 2001.

  77. Li JT, Bonneau LA, Zimmerman JJ, Weiss DJ. Perfluorochemical (PFC) Liquid Enhances Adenovirus-Mediated Viral Interleukin-10 (AdvIL-10) Transgene Expression in Rodent Lung. Mol Therapy 3:A480 2001.

  78. Weiss DJ, Baskin GB, Shean MK, Blanchard JL, Kolls JK. Perflubron Enhances Adenovirus-Mediated Gene Expression in Lungs of Spontaneously Breathing Non-Human Primates. Mol Therapy 3:A954 2001.

  79. Weiss DJ, Bonneau L, Liggitt D. Use of Perfluorochemical Liquid Enhances Adenovirus Mediated Lung Gene Expression by Transiently Opening Tight Junctions Between Airway Epithelial Cells Am J Resp Crit Care Medicine 163:A526 2001.

  80. Weiss DJ, Multu G, Bonneau L, Mendez M, Dumasius V, Factor P. Comparison of Surfactant and Perfluorochemical (PFC) Liquid Enhanced Adenovirus-Mediated Transgene Expression in Lung. Am J Resp Crit Care Medicine 163:A526 2001.

  81. Weiss DJ, Baskin GB, Shean MK, Blanchard JL, Kolls JK. Use of perfluorochemical liquid to enhance adenoviral-mediated gene expression in lungs of spontaneously breathing non-human primates: Feasibility and initial studies. Ped Pulmonol Suppl. 20:A225 2000.

  82. Bonneau LA, Liggitt HD, Weiss DJ. Pre-treatment with perfluorochemical liquid enhances adenoviral-mediated gene expression in lung. Ped Pulmonol Suppl. 20:A224 2000.

  83. Bonneau L, Shaffer TH, Lukason M, St. George J, Wolfson MH, Weiss DJ. Ingestion in vivo by alveolar macrophages of perfluorochemical (PFC) liquid correlates with altered pro-inflammatory cytokine release. Am J Resp Crit Care Med. 161:A902 2000.

  84. Weiss DJ, Strandjord TP, Bonneau L, Liggitt D, Lukason M, St. George J. Enhanced adenoviral-mediated gene expression in lung. Altered inflammatory response to adenoviral vectors with use of perfluorochemical (PFC) liquids. Ped Pulmonol Suppl. 19:A227 1999.

  85. Munson KL, Weiss DJ, Strandjord TP, Lynch CM. Improved detection of AAV transduction in lung. Pediatric Pulmonology Suppl. 19:A234 1999.

  86. Weiss DJ, Munson K, Strandjord TP, Lynch CM. Improved detection of AAV transduction in lung and further augmentation with perfluorochemical liquids. Abstract presented at the American Society of Gene Therapy 1999 Meeting.

  87. Weiss DJ, Strandjord TP, Lukason M, Liggitt D, St. George J. Use of perfluorochemical liquids for intratracheal gene delivery: Need for less adenoviral vector and blunting of adenoviral-stimulated TNFa in BAL fluid. Abstract presented at the American Society of Gene Therapy 1999 Meeting.

  88. Strandjord TP, Madtes DK, Weiss DJ, Sage EH. Collagen accumulation is decreased in SPARC-knockout mice in an intratracheal bleomycin model of pulmonary fibrosis. Abstract prented at the American Lung Association/American Thoracic Society 1999 Meeting. (Am J Resp Crit Care Med 159:A196 1999).

  89. Weiss DJ, Strandjord TP, Liggitt HD, Clark JG. Enhanced adenoviral-mediated gene delivery to lungs of rats with acute bleomycin-induced lung injury using perfluorochemical liquids. Abstract presented at the American Lung Association/American Thoracic Society 1999 Meeting. (Am J Resp Crit Care Med 159:A434 1999).

  90. Weiss DJ, Strandjord TP, Liggitt HD, Clark JG. Perfluorochemical liquids enhance gene delivery to lungs of transgenic mice with chronic alveolar filling. Abstract presented at the American Lung Association/American Thoracic Society 1999 Meeting. (Am J Resp Crit Care Med 159:A434 1999).

  91. Weiss DJ, Gurpide E.  Carbachol-stimulated phosphoinositide hydrolysis in a human endometrial adenocarcinoma cell line.  Abstract presented at the 3rd Annual Colloquium in Biological Sciences, New York Academy of Sciences, New York, November 1985.

  92. Weiss DJ, Gurpide E.  Characterization of phosphoinositide hydrolysis in a human endometrial carcinoma cell line.  FASEB, St. Louis, April 1986

  93. Weiss DJ, Richards C, Dunaif A. Increased prevalence of polycystic ovarian syndrome in Caribbean Hispanic women.  Abstract presented at the Eastern Student Research Forum, Miami, Florida, March 1988

  94. Weiss DJ, Charles MA, Dunaif A, Herman H, Knowler WC, Lillioja S.  Hyperinsulinemia is associated with elevated serum androgens in Pima women with menstrual irregularities however is negatively correlated with androgens in women with normal menses.  Abstract presented at the 14th International Diabetes Federation Congress Satellite Meeting, Epidemiology of Diabetes and Its Complications, Williamsburg, VA, June 1991.

  95. Weiss DJ, Curiel DT, Kay MA, Clark JG.  Efficiency of gene transfer into cultured primary rat lung fibroblasts using different transfection vectors.  Am J Resp Crit Care Med, 151:A541 1995.

  96. Weiss DJ, Clark JG.  Endogenous b-galactosidase activity may confound evaluation of Lac-Z reporter gene transfer to lung parenchyma in models of acute lung injury.  Abstract presented at the “Gene Therapy for Acquired Diseases” Meeting, Nashville October 1995.

  97. Weiss DJ, Liggitt D, Clark JG.  Histochemical detection of endogenous b-galactosidase activity in lung using X-gal reagant. Am J Resp Crit Care Med, 153:A1154 1996.

  98. Weiss DJ, Standjord TP, Jackson CJ, Liggitt D, Clark JG.  Perfluorochemical liquid enhanced gene delivery to lungs of spontaneously breathing rodents.  Am J. Resp Crit Care Med, 157:A479  1998

  99. Weiss DJ, Niven RW, Strandjord TP, Liggitt D, Clark JG.  Perfluorochemical liquid-enhanced liposomal-mediated gene transfer to lungs of spontaneously breathing rats.   Ped Pulmonology 17:269  1998.

 Book Chapters

15 book chapters listed most recent to earliest, beginning in 2001

  1. Tanneberger AE, Weiss DJ, Uriarte JJ.   Decellularization and Recellularization Methods for Avian Lungs: An Alternative Approach for Use in Pulmonary Therapeutics.  In: Bioengineering Technologies.  Springer 2020. 

  2. Enes SR, Uriarte JJ, Pouliot RA, Weiss DJ.  Clinical Application of Stem/Stromal Cells in COPD.  In: Stem Cell-Based Therapy for Lung Disease. Springer 2020.

  3. Uhl FE, Wagner DE, Weiss DJ. Preparation of Decellularized Lung Matrices for Cell Culture and Protein Analysis.  Methods Mol Biol. 2017;1627:253-283. doi: 10.1007/978-1-4939-7113-8.

  4. Wagner DE, Uhl FE, Konigshoff M, Weiss DJ.  Ex Vivo Lung Bioengineering.  In Lung Stem Cells in the Epithelium and Vasculature.  Amy Firth and Jason X-J Yaun, Editors.  Human Press 2015.

  5. Cruz, FF, Rocco, PRM, Weiss DJ. Mesenchymal Stromal Cell-Based Therapies for Lung Diseases and Critical Illnesses In: Stem Cells. Tissue Engineering and Regenerative Medicine. World Scientific, 2015.

  6. Cruz FF, Rocco PRM, Weiss DJ.  Challenges of Cell Therapy for Lung Diseases and Critical Illnesses.  In Lung Stem Cells in the Epithelium and Vasculature.  Amy Firth and Jason X-J Yaun, Editors.  Human Press 2015

  7. Wagner, DE, Uhl FE, Weiss DJ.  Acellular lung scaffolds in lung bioengineering. Stem Cell Biology and Regenerative Medicine: Stem Cells in the Lung, Springer 2015.

  8. Wagner DE, Uhl FE, Königshoff M, Weiss DJ. Ex vivo lung bioengineering Stem Cells and Regenerative Medicine Series: Lung Stem Cells in the Epithelium & Vasculature, Springer 2014.

  9. Weiss DJ, Rojas M. MSCs in chronic lung diseases: COPD and lung fibrosis in stem cell-dependent therapies-mesenchymal stem cells in chronic inflammatory disorders. In Mesenchymal Stem Cells in  Health and Disease.  DeGruyter Press, Berlin 2013.

  10. Weiss DJ. Mesenchymal Stem Cells for Lung Repair and Regeneration. In Stem Cells and  Cell Therapies in Lung Biology and Diseases  Mauricio Rojas, Editor, Springer, 2010.

  11. Weiss DJ. A General review of the Current Status of Cell Therapies for Lung Disorders In Cell Therapy for Lung Repair  Dame Julia Polak, Editor.  Imperial Press London, 2009

  12. Sueblinvong V, Weiss DJ. Repair of the Lung Epithelium in Cystic Fibrosis.  In Cell Therapy for Lung Repair  Dame Julia Polak, Editor.  Imperial Press London, 2009.

  13. Weiss DJ.  Delivery of DNA to Lung Airway Epithelium.  In Gene Delivery to Mammalian Cells: Methods and Protocols, William Heiser, Editor (Methods in Molecular Biology series, Humana Press Inc. 2003.).

  14. Weiss DJ.  Gene Therapy and Gene Transfer Approaches for Acute Lung Injury.  In Gene Therapy and Lung Disease Steven Albelda, Editor (in NHLBI Lung Biology in Health and Disease Series, Claude Lenfant, Executive Editor.  Marcel Dekker 2002.).

  15. Weiss DJ.  Gene Delivery in the ICU.  In Molecular Interventions: Gene Therapy for the ICU.  Phillip Factor, Editor.  Plenum Press 2001.